Business & Finance
Boehringer Ingelheim reports strong 2022 performance
30 March 2023 - Germany-based pharmaceutical company Boehringer Ingelheim reported on Wednesday a strong performance in 2022.The company stated that 2022 was a year in which 30 million patients benefi...
Navamedic ASA announces cash offer to acquire all Sensidose AB shares
30 March 2023 - Navamedic ASA (OSE:NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, announced on Wednesday that it has submitted a cash offer to acquir...
Navamedic announces cash offer to acquire Sensidose for approximately SEK75m
29 March 2023 - Nordic pharmaceutical company Navamedic ASA (OSE:NAVA), disclosed on Wednesday that it has submitted a cash offer of approximately SEK75m to acquire all shares in Sensidose AB, a Swede...
European Commission Grants Orphan Designation for iECURE's Lead Product Candidate GTP-506 for the Treatment of Ornithine Transcarbamylase Deficiency
24 March 2023 - - The European Commission granted orphan designation for US-based gene editing company iECURE's lead product candidate GTP-506 for the treatment of Ornithine Transcarbamylase defi...
Xeris Biopharma achieves fourth quarter net product revenue of USD32.5m
8 March 2023 - Biopharmaceutical company Xeris Biopharma Holdings Inc (Nasdaq: XERS) reported on Wednesday that it achieved a record-breaking quarter ended 31 December 2022, with net product revenue g...
Amgen announces Q2 2023 dividend
8 March 2023 - Biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Tuesday its dividend for the second quarter of 2023.The board of directors has declared a dividend of USD2.13 per share.The di...